Larry L. Wood, Global President TAVR & Surg at Edwards Lifesciences Corp (EW), sold 17,320 shares at $90.71 ($1.6M) on 2023-06-14, disclosed to the SEC on 2023-06-14.
Scheduled sale ($1.6M) by Global President TAVR & Surg under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.87 | 5,810 | $522K | 33.4% |
| 2 | $89.87 | 5,810 | $522K | 33.4% |
| 3 | $90.71 | 2,850 | $259K | 16.6% |
| 4 | $90.71 | 2,850 | $259K | 16.6% |
| Total | $90.15 avg | 17,320 | $1.6M | 100% |
| Filing → |
| EW | SELL | 2025-06-16 | $1.3M | — | Filing → |
| EW | SELL | 2024-11-05 | $1.6M | — | Filing → |
| EW | SELL | 2023-12-13 | $1.2M | — | Filing → |